October 2022 - Zahrawi

Zahrawi Group – Oman – Urology & Gastroenterology Unit participated in the 3rd Oman Urological Society Conference (OUSC 2022) held on 6-8 October 2022 at the Avani Hotel, Muscat, Oman.

This year’s edition gathered delegates, local, regional, and international speakers and was designed to provide an innovative and comprehensive overview of the latest research developments in the field of Urology. The conference featured symposia, keynote sessions, parallel workshops, and abstract presentations, hands on training on the latest treatment in Urology, Reproductive/Infertility Medicine to Laparoscopy & Robotics in Urology.

For their first participation at a Urology conference, Zahrawi Oman team grasped this opportunity to showcase the latest Urology solutions from our partner Boston Scientific, Laborie and EDAP offering a comprehensive portfolio of solutions to treat kidney stones, BPH (Rezūm), erectile dysfunction, male stress incontinence and pelvic floor disorders, ESWL, Urethral stricture (Optilume), Uroflowmetry & Urodynamics to continually advance the quality of patient care with innovative urology solutions.

Overall, our first participation in the 3rd Oman Urological Society Conference was very successful and this will be a start point to many more conferences for our Oman urology team.

Zahrawi Group Commercial, Regulatory and Quality teams attended the 2^nd Bahrain Health Regulatory Conference organized by the National Health Regulatory Authority (NHRA) held on 29^th September to 1^st October at Crowne Plaza Hotel, Bahrain.

The conference covered a variety of topics such as granting and renewing accreditation to hospitals and medical centers involving the Medical Devices and Pharmaceutical Importation and Registration authorities in Bahrain.

Our teams actively took part in networking with high level regulators and healthcare professionals, as part of our continuous mission to provide and deliver the best healthcare solutions in Bahrain.

Overall, our participation in the 2^nd Bahrain Health Regulatory Conference and Exhibition was very productive and we were honoured to meet Dr Mariam Al-Jalahma, NHRA Executive CEO, and the Medical Devices regulating team, to discuss the challenges and achievements during 2022.